UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement | |||||
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |||||
| ☐ | Definitive Proxy Statement | |||||
☒ | Definitive Additional Materials | |||||
| ☐ | Soliciting Material under §240.14a-12 | |||||
Bionano Genomics, Inc. | ||||||
| (Name of Registrant as Specified In Its Charter) | ||||||
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) | ||||||
Payment of Filing Fee (Check all boxes that apply):
| ☒ | No fee required | ||
| ☐ | Fee paid previously with preliminary materials | ||
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 | ||
